Findings of the current study that decreased levels of TRIP13 observed in PNPT1 knockdown CRC cells, but not down‐regulation of PNPT1 expression in TRIP13‐inhibited cells, suggest its interacting partner, PNPTI, regulates the oncogenic functions of TRIP13. This evidence concerns the gene TRIP13 and colorectal carcinoma.